Last week Pedro Silva, President of the Direction, and Bárbara Gomes, AccelBio's CEO, were in Tel Aviv to get to know the Israeli innovation ecosystem.

With meetings with Tel Aviv University (Blavatnik Center for Drug Discovery) and Weizmann Institute of Science (Bina and Yeda), this was an excellent opportunity to learn about different perspectives and methodologies in the area of academic innovation and technology transfer.

We look forward to continuing our collaboration in the future.